PROSTATE GU011

Study #GU011

A Phase II Double-Blind, Placebo-Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN)

Back To Clinical Trials NCI Database Entry